What Are Peptides? A Beginner's Guide to Metabolic & Hormonal Health

Most conversations about metabolic health eventually land on the same short list — blood sugar, insulin, weight, hormones. What rarely gets explained is the molecular infrastructure connecting all of them. Peptides are that infrastructure. They are not a supplement trend or an experimental therapy. They are among the most fundamental signalling molecules your body produces, and many of the metabolic conditions we treat at Meto — insulin resistance, PCOS, obesity, hormonal dysregulation — are, at their root, disorders of peptide communication.

This guide is written for people who want to understand what is actually happening in their biology, not just what label their doctor gave their symptoms. We will cover what peptides are, how they work, how they differ from hormones, which ones matter most for your metabolic health, and what the current evidence says about therapies that involve them. No biochemistry degree required.

What Are Peptides? 

Peptides are short chains of amino acids — typically between 2 and 50 — joined together by peptide bonds. They occupy the molecular space between individual amino acids and full proteins. If amino acids are letters, peptides are words, and proteins are paragraphs. The distinction matters clinically: proteins are large, structurally complex molecules that mostly serve structural or enzymatic roles. Peptides are compact and fast-acting, built for signalling.

Your body synthesises thousands of them. A 2013 review in Chemical Biology & Drug Design noted that over 7,000 naturally occurring peptides have been identified in human biology, acting across virtually every physiological system — cardiovascular, immune, endocrine, neurological, and digestive.

Where do peptides come from?

Peptides have three main origins:

Endogenous — made by the body. Insulin, glucagon, GLP-1, leptin, and ghrelin are all endogenous peptides your pancreas, gut, and adipose tissue produce in response to what you eat, how you sleep, and how much you move.

Food-derived — released when dietary proteins are broken down in the gut. Collagen-derived peptides, bioactive peptides in dairy (particularly casein-derived), and certain plant-based peptides fall into this category. These can exert local effects on the gut lining and, in some cases, systemic effects after absorption.

Synthetic or therapeutic — laboratory-manufactured peptides that either mimic endogenous ones or are engineered for enhanced potency or stability. Semaglutide and tirzepatide — the most discussed metabolic medications of the last several years — are both synthetic peptide analogues.

Quick definition: A peptide is a short chain of amino acids. The amino acids that make up peptides are the same building blocks your body depends on for virtually every metabolic function. For a deeper look at how those building blocks work before they become peptides, see Meto's guide to amino acids and metabolic health.

How Peptides Work in the Body

Understanding peptide action does not require a pharmacology background. The mechanism is essentially this: a peptide is released from one tissue, travels to another, and binds to a specific receptor on the surface of a target cell — like a key fitting a lock. That binding event triggers a response inside the cell: produce more of this enzyme, release that hormone, slow down this process, accelerate that one.

The precision of this system is what makes it so medically important. Each peptide has specific receptor targets, which means each one can exert very targeted effects rather than broad, system-wide changes.

Three modes of peptide signalling

Depending on where a peptide acts relative to where it is released, it falls into one of three signalling modes:

Endocrine signalling — the peptide enters the bloodstream and acts on distant organs. Insulin is the clearest example: released by pancreatic beta cells in response to rising blood glucose, it travels to muscle, fat, and liver tissue to trigger glucose uptake.

Paracrine signalling — the peptide acts on neighbouring cells rather than travelling far. Local inflammatory peptides released during tissue injury work this way, recruiting immune cells to the site without triggering a systemic response.

Autocrine signalling — a cell releases a peptide that binds to receptors on itself. This self-regulatory loop plays a role in immune function and certain aspects of metabolic regulation.

What happens when peptide signalling fails?

Insulin resistance — which sits at the core of type 2 diabetes, metabolic syndrome, PCOS, and fatty liver disease — is, mechanistically, a failure of peptide-receptor communication. The pancreas produces adequate insulin (initially), but the target cells have become less sensitive to its signal. The key still works, but the lock has been changed. Over time, the pancreas compensates by producing more insulin, and the system deteriorates from there.

This is not a trivial framing choice. It means that addressing insulin resistance is, in a meaningful sense, a problem of restoring peptide signal fidelity — and it explains why both lifestyle interventions and pharmaceutical peptide therapies can move the needle on the same condition.

Peptides vs. Hormones — What's the Difference? 

This is one of the most common points of confusion in metabolic health discussions, and the answer is less of a clean distinction than most people expect.

Some hormones are peptides. Insulin, glucagon, GLP-1, leptin, ghrelin, and growth hormone are all peptide hormones — they are chemically peptides, and they function as hormones by travelling through the bloodstream to act on distant tissues.

Not all hormones are peptides. Steroid hormones — estrogen, testosterone, progesterone, cortisol, and aldosterone — are derived from cholesterol, not from amino acid chains. They are structurally and functionally distinct.

Not all peptides are hormones. Many peptides serve structural roles (collagen peptides), antimicrobial functions (defensins), or act as neurotransmitters (endorphins) without fitting the classical definition of a hormone.

Key differences at a glance

The clinical relevance: when patients with PCOS, perimenopause, or metabolic syndrome describe a "hormonal imbalance," the disruption often involves both peptide hormones (insulin, GLP-1, leptin) and steroid hormones (testosterone, estrogen, progesterone) — and the two systems interact. High insulin, for example, drives excess androgen production in PCOS, which is a steroid hormone problem downstream of a peptide hormone problem. Understanding that connection is part of why Meto approaches these conditions together rather than in isolation.

Types of Peptides

Peptides are classified in several overlapping ways. For clinical purposes, the most useful lens is function.

Hormonal peptides regulate systemic processes — metabolism, appetite, growth, and reproduction. These are the ones most directly relevant to metabolic health.

Neuropeptides act as signalling molecules in the nervous system. Endorphins, substance P, and neuropeptide Y fall here. The gut-brain axis — increasingly understood as a bidirectional communication network involving both the enteric nervous system and systemic circulation — relies heavily on neuropeptide signalling. GLP-1 is uniquely positioned as both a gut hormone and a neuropeptide, acting on the brain's appetite-regulating centres as well as on the pancreas.

Antimicrobial peptides are part of the innate immune system's first-line defence. Disruptions in these can contribute to chronic low-grade inflammation, which is itself a driver of metabolic dysfunction.

Structural peptides — most notably collagen peptides — provide the scaffold for connective tissue, including the gut lining. Degraded gut barrier integrity has been linked to impaired incretin hormone (GLP-1) secretion and systemic inflammation.

Signalling and regulatory peptides — a broad category covering cytokines, growth factors, and enzymatic regulatory peptides that modulate cellular processes without acting as classical hormones.

By length, peptides are sometimes described as dipeptides (2 amino acids), oligopeptides (3–10), and polypeptides (more than 10), with polypeptides shading into proteins above roughly 50 amino acids. Insulin, for reference, is a polypeptide of 51 amino acids — right at the boundary. For a deeper look at how amino acids connect to hormonal regulation across all these peptide categories, Meto's clinical team has covered that in detail.

Key Peptides for Metabolic and Hormonal Health 

These are the peptides that are most likely to appear in your clinical picture — either in your lab results, your treatment plan, or your clinician's explanation of what is driving your symptoms.

Insulin

Insulin is a 51-amino-acid polypeptide produced by pancreatic beta cells in direct response to rising blood glucose. Its primary role is to facilitate glucose uptake into cells. When tissues resist insulin's signal, blood glucose stays elevated, beta cells are pushed harder, and the resulting hyperinsulinaemia contributes to fat storage, inflammation, arterial damage, and — in women with relevant genetic susceptibility — excess androgen production.

Fasting insulin is one of the most informative early markers of metabolic dysfunction, often rising years before blood glucose abnormalities appear. Yet it is routinely omitted from standard metabolic panels. Reading your metabolic panel results without fasting insulin in the picture leaves a significant blind spot.

GLP-1 (Glucagon-Like Peptide-1)

GLP-1 is a 30-amino-acid incretin hormone secreted by L-cells in the small intestine and colon in response to nutrient intake. Its effects are broad: it stimulates insulin secretion (in a glucose-dependent fashion, which limits hypoglycaemia risk), suppresses glucagon, slows gastric emptying, and signals satiety to the brain via the vagus nerve and hypothalamic receptors.

Drucker DJ's seminal 2006 review in Physiological Reviews established GLP-1 as a central orchestrator of the postprandial metabolic response. Gut dysbiosis, ultra-processed food consumption, and intestinal inflammation all impair native GLP-1 secretion — which partly explains why these dietary patterns accelerate metabolic deterioration.

Therapeutic GLP-1 receptor agonists — semaglutide, tirzepatide, and related agents — are synthetic analogues engineered for longer half-lives than the endogenous peptide, which degrades within minutes. The 2021 STEP trial published in the New England Journal of Medicine demonstrated up to 14.9% mean body weight reduction with once-weekly semaglutide — a result achieved through peptide-receptor engagement, not appetite suppression through stimulant mechanisms. For clinical context on how these medications are monitored, see Meto's guide on questions to ask your doctor about GLP-1 lab work.

Leptin and Ghrelin — The Appetite Axis

Leptin is produced by adipose tissue and signals satiety to the hypothalamus — the brain's energy-balance regulator. In a functioning system, more body fat means more leptin, which means less hunger. In leptin resistance — which, like insulin resistance, is common in metabolic syndrome — the signal fails to register despite elevated leptin levels. The brain perceives starvation while the body carries excess energy stores.

Ghrelin, produced primarily in the stomach, drives hunger and peaks before meals. Sleep deprivation substantially raises ghrelin levels — a mechanistic explanation for why poor sleep reliably increases food intake and is associated with weight gain. A 2007 review in Obesity Reviews by Klok et al. remains a foundational summary of both peptides' roles in human appetite regulation.

IGF-1 (Insulin-Like Growth Factor-1)

IGF-1 is a polypeptide produced primarily in the liver in response to growth hormone signalling. It mediates most of growth hormone's anabolic effects: muscle protein synthesis, fat mobilisation, and cellular repair. IGF-1 declines with age, which contributes to the lean mass loss, increased visceral adiposity, and metabolic slowing seen in andropause, menopause, and general ageing. Clinically, IGF-1 is often measured alongside growth hormone as part of a more complete metabolic and longevity panel.

Collagen Peptides — The Structural Layer

Collagen is the most abundant protein in the body, and its degradation products — collagen peptides, particularly di- and tripeptides like Pro-Hyp — are absorbed intact and appear to stimulate fibroblast collagen synthesis. A 2015 study in the British Journal of Nutrition by Zdzieblik et al. found that collagen peptide supplementation in combination with resistance training improved body composition and muscle strength in elderly men compared to a placebo group. Evidence for gut lining support and joint health is developing, though currently less definitive. Collagen peptides are food-derived (bone broth, hydrolysed collagen powders) and carry a good safety profile — they are not in a regulatory grey zone the way many therapeutic peptides are.

Peptides and Your Lab Results 

Several standard and specialist laboratory tests measure peptides directly or measure their downstream effects. Understanding what you are actually looking at helps you have more informed conversations with your clinical team.

Fasting Insulin and C-Peptide

Fasting insulin directly measures circulating insulin levels under fasting conditions. Elevated fasting insulin (generally above 10 µIU/mL, though optimal ranges are debated) suggests insulin resistance is already present even when fasting glucose appears normal.

C-peptide is a byproduct of insulin synthesis. When beta cells produce insulin, they release an equal amount of C-peptide — making C-peptide a more stable and accurate marker of how much insulin your own pancreas is actually making. This is particularly useful in distinguishing type 1 from type 2 diabetes, and in assessing residual beta cell function. A 2017 clinical review in Diabetic Medicine by Leighton et al. outlines C-peptide's evolving clinical utility in detail.

HbA1c and Fasting Glucose

These are not peptide measurements directly, but they reflect insulin peptide dysfunction. HbA1c captures average blood glucose over the preceding 2–3 months — a period long enough to smooth out daily variation. Fasting glucose captures a single point. Used together with fasting insulin and C-peptide, they build a layered picture of where the glucose-insulin axis sits.

IGF-1 Panel

Growth hormone and IGF-1 are typically measured together to assess the pituitary-liver growth hormone axis. Low IGF-1 relative to age is associated with reduced lean mass, increased fat mass, and impaired metabolic rate — all of which compound other metabolic dysfunction.

Hormone Panels — The Wider Peptide Context

For patients with PCOS, irregular cycles, suspected perimenopause, or andropause, hormone panels include LH and FSH — both peptide hormones secreted by the pituitary. Their ratios and absolute values help establish whether hormonal dysregulation originates centrally (the pituitary) or peripherally (the ovaries, testes, or adrenal glands). Meto's PCOS lab panel guide covers this in clinical detail, including the role of fasting insulin in the PCOS diagnostic picture.

Questions worth raising with your clinician

• Has my fasting insulin been tested, or just fasting glucose?
• Should I have a C-peptide measured to assess beta cell function?
• Is an IGF-1 panel appropriate given my symptoms?
• Are my LH and FSH levels consistent with where I am in my hormonal cycle or life stage?

If you are preparing for lab testing and are not sure which panel covers which markers, Meto's comprehensive metabolic panel is designed to capture the most clinically informative picture with one draw.

Clinical note: The information in this article is educational. Laboratory results should always be interpreted in the context of your full clinical history by a qualified clinician.

Peptide Supplements and Therapies — What the Evidence Actually Says 

The peptide supplement market has expanded significantly, and the quality of evidence behind different products and therapies varies enormously. A working framework:

The bioavailability problem — what survives digestion?

Peptides consumed orally face a fundamental challenge: the digestive system is designed to break them down into individual amino acids. Larger peptides, in particular, rarely reach systemic circulation intact. This is why therapeutic peptide drugs — insulin, GLP-1 agonists — are typically delivered by injection.

The exception is small food-derived peptides (di- and tripeptides) that are absorbed via specific intestinal transporters. Collagen hydrolysate products are formulated to produce these short-chain peptides, and some oral bioavailability has been demonstrated. As Vlieghe et al. noted in a 2010 Drug Discovery Today review, oral bioavailability remains the primary technical barrier for peptide therapeutics — and this challenge has not been resolved for most compounds marketed as oral peptide supplements.

Therapeutic peptide medications — the regulated category

This is where the clinical evidence is strongest. GLP-1 receptor agonists (semaglutide, tirzepatide), insulin analogues, and growth hormone secretagogues like sermorelin are regulated pharmaceutical products, prescribed after clinical assessment, and monitored during use. Their mechanisms are well-characterised, their trial data is robust, and their risk profiles are documented.

The FDA has been actively reviewing the regulatory status of compounded peptides — including BPC-157, TB-500, and others frequently marketed for recovery and metabolic benefits. Meto's clinical team has covered this landscape in detail in a guide to the FDA's 2026 peptide advisory considerations. The short version: compounding status and FDA approval are not the same thing, and patients deserve clarity on that distinction.

Research peptides and grey-market products

A substantial category of peptides is sold online — often labelled "for research use only" — and used without prescription or medical supervision. The honest clinical position is that most of these compounds lack the human trial data that would establish both efficacy and safety. Some show genuinely interesting preclinical results; that does not translate to clinical validation. Purity, dosing accuracy, and contamination risk in unregulated products are real concerns.

If you are considering any peptide therapy, that conversation should happen with a clinician who can assess your specific metabolic picture, not with a supplement retailer.

Supporting endogenous peptide production — lifestyle as the foundation

Your body's own peptide output is not fixed. Several well-evidenced levers move it in meaningful ways:

Protein-adequate diet: The amino acids that form your endogenous peptides come from dietary protein. Inadequate protein intake — particularly common in older adults — limits the raw material available for peptide synthesis. For a breakdown of which amino acids matter most and why, Meto's clinical team has covered the essential nine in detail.

Sleep: Growth hormone — itself a peptide — is released in pulses primarily during slow-wave sleep. Ghrelin, the hunger peptide, rises with sleep debt. Prioritising sleep is not a soft lifestyle recommendation in this context; it is a direct intervention in your peptide signalling environment.

Exercise: Resistance training stimulates IGF-1 release and supports lean mass maintenance. Aerobic exercise increases GLP-1 secretion and improves insulin sensitivity — a downstream measure of improved peptide receptor function.

Gut microbiome health: L-cells, which produce GLP-1, are heavily influenced by the microbial composition of the gut. Fibre-rich diets that support Bacteroides, Bifidobacterium, and Lactobacillus species are associated with improved incretin secretion — which is one mechanism through which dietary patterns influence metabolic risk independent of caloric content.

Meto's Perspective on Peptide-Based Care 

At Meto, we do not treat peptides as a trend. We treat them as what they are: the molecular machinery through which your metabolic and hormonal health either functions or fails. The conditions we work with most often — insulin resistance, PCOS, metabolic syndrome, weight dysregulation, perimenopause, and andropause — all involve disrupted peptide signalling at their core.

That means two things clinically. First, the lab panel we order needs to actually measure what is happening at the peptide level — fasting insulin, C-peptide, IGF-1, and the full hormonal axis — not just fasting glucose and a lipid panel. Second, when peptide-based therapies are appropriate — whether GLP-1 receptor agonists, growth hormone secretagogues, or other regulated agents — they should be initiated with proper baseline assessment, monitored during use, and integrated into a broader metabolic care plan rather than issued in isolation.

What we consistently see is that patients who have been told their labs are "normal" still have clear evidence of peptide dysfunction when the right tests are ordered. Fasting insulin that sits at 18 µIU/mL is not normal. A GLP-1 response that flatlines after a meal is not normal. These are treatable findings — but only if someone looks for them.

Peptide-based care at Meto is not about prescribing a medication. It is about understanding your signalling environment — what your body is producing, what it is responding to, and where the communication has broken down — and building a targeted plan from that foundation.

Ready to understand your peptide biology?

Talk to a Meto clinician about peptide-based care.

If you are experiencing fatigue, weight resistance, blood sugar irregularities, hormonal symptoms, or simply want a clearer picture of what your metabolic labs actually mean, our clinical team can order the right panel, interpret the results in context, and design a care plan built around your specific biology — not a generic protocol.

Start with a Meto assessment →

Most visits cost $0–50 with insurance. Self-pay options are available.

Frequently Asked Questions 

What are peptides in simple terms?

Peptides are short chains of amino acids — the same building blocks that make proteins — that act as biological messengers in the body. Your body makes thousands of them. Insulin, the hormone that regulates blood sugar, is a peptide. So is GLP-1, the gut hormone that signals fullness after eating.

What is the difference between peptides and proteins? 

Length and function. Peptides are generally 2–50 amino acids long and act primarily as signalling molecules. Proteins are longer, more structurally complex, and serve a wider range of structural and enzymatic roles. The boundary between the two is not absolute — insulin, at 51 amino acids, sits right at the edge.

Is insulin a peptide or a hormone? 

Both. Insulin is a peptide hormone — it is chemically a peptide (a polypeptide of 51 amino acids) and it functions as a hormone by travelling through the bloodstream to regulate glucose uptake in distant tissues.

How do peptides affect weight and metabolism? 

Several key metabolic peptides regulate appetite (ghrelin, leptin), insulin secretion (GLP-1, GIP), fat storage (insulin), and energy expenditure (IGF-1, growth hormone). When these signalling systems are disrupted — as in insulin resistance or leptin resistance — weight management becomes physiologically difficult, not just a matter of willpower. Therapeutic GLP-1 receptor agonists work by restoring or amplifying one of the most important satiety signals in this system.

What is the difference between a peptide and a steroid? 

Peptides are made from amino acids and are water-soluble. Steroid hormones — like testosterone, estrogen, and cortisol — are derived from cholesterol and are fat-soluble. They work through different receptor mechanisms: peptides bind to receptors on the cell surface; steroids pass through the cell membrane and act on nuclear receptors inside the cell. Both categories are critical to metabolic and hormonal health.

Are GLP-1 medications like Ozempic peptides? 

Yes. Semaglutide (the active molecule in Ozempic and Wegovy) is a synthetic analogue of the naturally occurring peptide GLP-1. It has been modified to resist the rapid enzymatic degradation that limits the native peptide to a half-life of minutes, giving semaglutide a half-life of approximately one week — hence the once-weekly dosing.

Can you get peptides from food? 

Yes, particularly collagen peptides from bone broth, skin, and connective tissue in animal products, and bioactive peptides released during the digestion of dairy proteins. Food-derived peptides are generally absorbed as short chains (di- and tripeptides) and do not replicate the systemic effects of endogenous signalling peptides, but they contribute to local gut health and certain downstream metabolic functions.

What is a C-peptide test, and when would I need one? 

C-peptide is a molecule released alongside insulin when your pancreas produces it. Because it degrades more slowly than insulin, it is a more stable and accurate measure of how much insulin your body is making. Your clinician might order it to distinguish between type 1 and type 2 diabetes, to assess residual beta cell function, or to investigate unexplained hypoglycaemia. It is also useful in patients on insulin therapy, where direct insulin measurement becomes confounded.

Do peptide supplements actually work? 

It depends on the peptide and the delivery method. Collagen hydrolysate supplements (which deliver small collagen peptides) have reasonable evidence for supporting connective tissue synthesis when taken with adequate vitamin C and combined with resistance training. Oral supplements claiming to deliver large therapeutic peptides like growth hormone fragments or complex signalling peptides face significant bioavailability challenges that most products do not adequately address. Prescription peptide therapies — GLP-1 agonists, insulin, sermorelin — have robust clinical trial data behind them and are delivered in ways that preserve bioavailability.

Next Reads on Meto

• Amino Acids for Metabolic Health: The Complete Clinical Guide
• 9 Essential Amino Acids Explained: Benefits, Functions & Food Sources
• Top 10 Questions to Ask Your Doctor About GLP-1 Lab Work
• PCOS Lab Panel: The Complete Guide to Testing for Polycystic Ovary Syndrome
• Metabolic Panel Results Explained: How to Read Your CMP & BMP
• FDA July 2026 Peptide Meeting: What Patients Need to Know
• 8 Reasons to Get Lab Work Before Starting Any Weight Loss Program

This article is for educational purposes and does not constitute medical advice. Always consult a qualified clinician before making changes to your care plan or interpreting laboratory results.